Stocklytics Platform
Asset logo for symbol ABBV
AbbVie
ABBV60
$193.39arrow_drop_up0.27%$0.53
S&P500
Asset logo for symbol ABBV
ABBV60

$193.39

arrow_drop_up0.27%

Income Statement (ABBV)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT$5.08B$2.98B$2.10B$246.00M$6.77B
EBITDA$5.08B$5.06B$4.18B$2.44B$6.77B
gross Profit$12.28B$8.22B$11.91B$7.44B$9.62B
NET Income$1.37B$1.36B$822.00M$1.77B$2.02B
total Revenue$14.46B$12.31B$14.30B$13.92B$13.86B

Balance Sheet (ABBV)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt$57.50B$55.93B$46.57B$47.45B$52.25B
stockholders Equity$6.77B$8.00B$10.36B$12.09B$12.86B
total Assets$141.93B$148.87B$134.71B$136.22B$135.36B
total Debt$70.63B$74.00B$59.38B$60.74B$61.01B
total Liabilities$135.11B$140.82B$124.31B$124.09B$122.46B

Cash Flow (ABBV)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow-$6.09B$10.81B-$4.44B-$2.66B-$3.92B
free Cash Flow$2.03B$3.84B$4.54B$7.35B$6.14B
investing Cash Flow--$9.58B-$800.00M-$369.00M-$341.00M
operating Cash Flow$2.27B$4.04B$4.75B$7.57B$6.31B

AbbVie (ABBV) Financials

AbbVie Inc (ABBV) is a pharmaceutical company that specializes in the research and development of innovative medical products. The company's financials provide valuable insights into its performance and growth. The income statement reveals the company's revenue, expenses, and net income. For AbbVie Inc, the income statement shows a strong performance with a significant gross profit and a substantial net income from stockholders. The total revenue for AbbVie Inc showcases the company's success in generating sales and maintaining its position in the market. The balance sheet reflects the company's financial position, including its assets, liabilities, and stockholders' equity. AbbVie Inc has a solid balance sheet with a substantial amount of total assets and a healthy stockholders' equity. The cash equivalents are important indicators of a company's liquidity and financial stability. For AbbVie Inc, the cash equivalents indicate that the company has sufficient funds to meet its short-term obligations. The net debt reveals the extent to which a company relies on debt financing. AbbVie Inc has a reasonable amount of net debt, indicating a conservative approach to borrowing. The financing cash flow represents the inflows and outflows of cash related to financing activities. For AbbVie Inc, the financing cash flow shows the company's ability to raise capital and repay debt. The free cash flow is an important metric for evaluating a company's financial health. AbbVie Inc has a strong free cash flow, indicating that the company has enough cash to invest in growth opportunities and return value to shareholders. The investing cash flow reflects the company's cash flows from investing activities. For AbbVie Inc, the investing cash flow shows the company's investments in research and development, acquisitions, and capital expenditures. The operating cash flow represents the cash the company generates from its core operations. AbbVie Inc has a robust operating cash flow, indicating that the company is generating cash from its core business activities and is in a strong financial position.
Overall, AbbVie Inc's financials demonstrate the company's strong performance, financial stability, and ability to generate cash. The income statement, balance sheet, and cash flow statement all provide valuable insights into the company's operations and financial health. With a significant gross profit, healthy net income from stockholders, and substantial total revenue, AbbVie Inc is well positioned for continued growth and success in the pharmaceutical industry. The company's solid balance sheet, ample cash equivalents, and reasonable net debt further underscore its financial stability. Moreover, the strong financing cash flow, free cash flow, investing cash flow, and operating cash flow demonstrate AbbVie Inc's ability to raise capital, make strategic investments, and generate cash from its core operations. These financial indicators highlight AbbVie Inc's prudent financial management and commitment to creating value for its shareholders.
add AbbVie  to watchlist

Keep an eye on AbbVie

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media